Gottlieb, AB, A Blauvelt, D Tha?i, Y Poulin, F Brock, C Arendt, M Boehnlein, and K Reich. 2020. “Reductions in Absolute PASI Over 144 Weeks of Treatment With Certolizumab Pegol in Patients With Plaque Psoriasis: Pooled Analysis from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 4 (6):s84. https://doi.org/10.25251/skin.4.supp.84.